Methotrexate (M) sulfasalazine (S) hydroxychloroquine (H) combination therapy in ra patients: Efficacy and toxicity at 3 years.

被引：0
|
作者：
ODell, J
Haire, C
Drymalski, W
Palmer, W
Eckhoff, PJ
Maloley, P
Klassen, L
Wees, S
Klein, H
Moore, G
机构：
[1] UNIV NEBRASKA,MED CTR,OMAHA,NE 68198
[2] VET ADM MED CTR,OMAHA,NE 68198
来源：
ARTHRITIS AND RHEUMATISM | 1996年 / 39卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：R12 / R12
页数：1
相关论文
共 32 条
  • [1] Methotrexate (M) sulfasalazine (S) hydroxychloroquine (H) combination therapy in rheumatoid arthritis (RA): Continued efficacy with minimal toxicity at 3 years.
    ODell, J
    Haire, C
    Drymalski, W
    Palmer, W
    Eckhoff, PJ
    Maloley, P
    Klassen, L
    Wees, S
    Klein, H
    Moore, G
    [J]. ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 578 - 578
  • [2] Combination DMARD therapy with methotrexate (M) sulfasalazine (S) hydroxychloroquine (H) in rheumatoid arthritis (RA): Continued efficacy with minimal toxicity at 5 years.
    O'Dell, J
    Paulsen, G
    Haire, C
    Palmer, W
    Wees, S
    Eckhoff, J
    Klassen, L
    Moore, G
    [J]. ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S132 - S132
  • [3] EFFICACY OF COMBINATION THERAPY OF METHOTREXATE WITH HYDROXYCHLOROQUINE OR SULFASALAZINE IN RHEUMATOID ARTHRITIS PATIENTS IN KUMAON REGION: A COMPARATIVE STUDY
    Bharat, Suyash
    Srivastava, Bhavana
    Singh, Paramjeet
    Bhardwaj, Reena
    Gaur, Sanjay
    [J]. JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2016, 5 (51): : 3403 - 3407
  • [4] Comparison of efficacy and tolerability of triple combination therapy (methotrexate plus sulfasalazine plus hydroxychloroquine) with methotrexate monotherapy in patients with rheumatoid arthritis
    Gubar, E. E.
    Bochkova, A. G.
    Bunchuk, N., V
    [J]. TERAPEVTICHESKII ARKHIV, 2008, 80 (05): : 25 - 30
  • [5] Methotrexate(M)-hydroxychloroquine(H)-sulfasalazine(S) versus M-H or M-S for rheumatoid arthritis (RA): Results of a double-blind study.
    O'Dell, J
    Leff, R
    Paulsen, G
    Haire, C
    Mallek, J
    Eckhoff, PJ
    Fernandez, A
    Blakely, K
    Wees, S
    Hadley, S
    Felt, J
    Palmer, W
    Waytz, P
    Churchill, M
    Klassen, L
    Moore, G
    [J]. ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S117 - S117
  • [6] LIVER TOXICITY IS RARE IN RA PATIENTS USING COMBINATION THERAPY WITH LEFLUNOMIDE AND METHOTREXATE
    Alves, J. A. N. R.
    Zerwes, N.
    Morato, E. F.
    Zimmermann, A. F.
    Castro, G. R. W.
    Neves, F. S.
    Ribeiro, G.
    Pereira, I. A.
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2010, 16 (03) : S42 - S42
  • [7] Real-World Outcomes Associated With Methotrexate, Sulfasalazine, and Hydroxychloroquine Triple Therapy Versus Tumor Necrosis Factor Inhibitor/Methotrexate Combination Therapy in Patients With Rheumatoid Arthritis
    Curtis, Jeffrey R.
    Palmer, J. Lynn
    Reed, George W.
    Greenberg, Jeffrey
    Pappas, Dimitrios A.
    Harrold, Leslie R.
    Kremer, Joel M.
    [J]. ARTHRITIS CARE & RESEARCH, 2021, 73 (08) : 1114 - 1124
  • [8] COMPARISON OF EFFICACY BETWEEN COMBINATION THERAPY WITH IGURATIMOD AND SULFASALAZINE WITH METHOTREXATE IN JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS: PROPENSITY SCORE ANALYSIS
    Tokunaga, K.
    Shiraishi, A.
    Oshikawa, H.
    Hagino, N.
    Nishino, J.
    Tohma, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 278 - 278
  • [9] Sustained clinical efficacy and safety of combination therapy with etnaercept plus methotrexate in ra patients through 4 years: Tempo trial extension results
    Mola, E. Martin
    Van der Heijde, D.
    De Melo Gomes, J.
    Codreaunu, C.
    Fatenejad, S.
    MacPeek, D.
    Freundlich, B.
    Chang, D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 331 - 331
  • [10] Long-term prospective study of rheumatoid arthritis (RA) patients receiving methotrexate (MTX) therapy: Update after 13.3 years.
    Kremer, JM
    [J]. ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 456 - 456
1234